Christopher Jakubowski

1.0k total citations
20 papers, 702 citations indexed

About

Christopher Jakubowski is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Christopher Jakubowski has authored 20 papers receiving a total of 702 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 8 papers in Surgery and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Christopher Jakubowski's work include Renal cell carcinoma treatment (5 papers), Bladder and Urothelial Cancer Treatments (5 papers) and Genetic factors in colorectal cancer (3 papers). Christopher Jakubowski is often cited by papers focused on Renal cell carcinoma treatment (5 papers), Bladder and Urothelial Cancer Treatments (5 papers) and Genetic factors in colorectal cancer (3 papers). Christopher Jakubowski collaborates with scholars based in United States and United Kingdom. Christopher Jakubowski's co-authors include Nilofer S. Azad, Rebecca L. Siegel, Stacey A. Fedewa, Anjee Davis, Linda Hunt, Robert W. Wilkinson, Frank Marsh, C S Ogg, Stephen Bogle and R. A. Baillod and has published in prestigious journals such as The Lancet, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Christopher Jakubowski

18 papers receiving 681 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher Jakubowski United States 12 211 203 203 195 179 20 702
Isabel Martínez Spain 15 606 2.9× 130 0.6× 74 0.4× 153 0.8× 107 0.6× 33 1.2k
Marcel Soesan Netherlands 12 52 0.2× 64 0.3× 462 2.3× 139 0.7× 237 1.3× 23 912
Xiaojiang Zhan China 15 232 1.1× 140 0.7× 105 0.5× 64 0.3× 111 0.6× 65 844
Mark Jesky United Kingdom 16 221 1.0× 97 0.5× 48 0.2× 48 0.2× 178 1.0× 23 603
Alessandra Raimondi Italy 18 78 0.4× 233 1.1× 417 2.1× 383 2.0× 206 1.2× 71 926
Els Vercammen Belgium 10 115 0.5× 55 0.3× 433 2.1× 104 0.5× 103 0.6× 26 1.6k
Kun‐Yuan Chiu Taiwan 15 43 0.2× 187 0.9× 104 0.5× 379 1.9× 260 1.5× 99 804
Giuliano Boscutti Italy 14 235 1.1× 259 1.3× 25 0.1× 138 0.7× 82 0.5× 37 679
Habeeb Majeed Canada 11 45 0.2× 78 0.4× 138 0.7× 88 0.5× 27 0.2× 20 459
Soon Bae Kim South Korea 13 291 1.4× 207 1.0× 30 0.1× 84 0.4× 80 0.4× 25 614

Countries citing papers authored by Christopher Jakubowski

Since Specialization
Citations

This map shows the geographic impact of Christopher Jakubowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Jakubowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Jakubowski more than expected).

Fields of papers citing papers by Christopher Jakubowski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher Jakubowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Jakubowski. The network helps show where Christopher Jakubowski may publish in the future.

Co-authorship network of co-authors of Christopher Jakubowski

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher Jakubowski. A scholar is included among the top collaborators of Christopher Jakubowski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher Jakubowski. Christopher Jakubowski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Christenson, Eric S., Jeremiah A. Wala, Rose Parkinson, et al.. (2024). Abstract CT007: Phase 1/2 trial of copanlisib in combination with nivolumab for microsatellite stable (MSS) colorectal cancer (CRC). Cancer Research. 84(7_Supplement). CT007–CT007. 2 indexed citations
2.
Jakubowski, Christopher, Su Jin Lim, Andrew J. Pellatt, et al.. (2021). Clinical and molecular features of adenosquamous pancreatic cancer (ASQ): A distinct histological subtype.. Journal of Clinical Oncology. 39(3_suppl). 426–426. 1 indexed citations
3.
Jakubowski, Christopher & Nilofer S. Azad. (2020). Immune checkpoint inhibitor therapy in biliary tract cancer (cholangiocarcinoma). Chinese Clinical Oncology. 9(1). 2–2. 36 indexed citations
4.
Jakubowski, Christopher, et al.. (2020). A phase II trial of PD-1 inhibition with INCMGA00012 in patients with previously treated unresectable or metastatic adenosquamous pancreatic cancer.. Journal of Clinical Oncology. 38(15_suppl). TPS4662–TPS4662. 1 indexed citations
5.
Jakubowski, Christopher, Aditya Mohan, Ihab R. Kamel, & Mark Yarchoan. (2020). Response to Crizotinib in ROS1 Fusion–Positive Intrahepatic Cholangiocarcinoma. JCO Precision Oncology. 4(4). 825–828. 8 indexed citations
6.
Jakubowski, Christopher, et al.. (2020). A phase I/II study of PI3Kinase inhibition with copanlisib combined with the anti-PD-1 antibody nivolumab in relapsed/refractory solid tumors with expansions in MSS colorectal cancer.. Journal of Clinical Oncology. 38(15_suppl). TPS4114–TPS4114. 7 indexed citations
7.
Siegel, Rebecca L., Christopher Jakubowski, Stacey A. Fedewa, Anjee Davis, & Nilofer S. Azad. (2020). Colorectal Cancer in the Young: Epidemiology, Prevention, Management. American Society of Clinical Oncology Educational Book. 40(40). e75–e88. 167 indexed citations
8.
Vlachostergios, Panagiotis J., Christopher Jakubowski, Muhammad Junaid Niaz, et al.. (2018). Antibody-Drug Conjugates in Bladder Cancer. Bladder Cancer. 4(3). 247–259. 27 indexed citations
9.
Sinha, Rileen, Andrew Winer, Michael Chevinsky, et al.. (2017). Analysis of renal cancer cell lines from two major resources enables genomics-guided cell line selection. Nature Communications. 8(1). 15165–15165. 59 indexed citations
10.
Sankin, Alexander, Amy L. Tin, Roy Mano, et al.. (2016). Impact of Ureteroscopy Before Nephroureterectomy for Upper Tract Urothelial Carcinoma on Oncologic Outcomes. Urology. 94. 148–153. 32 indexed citations
11.
Jakubowski, Christopher, Andrew J. Plodkowski, Jason C. Chang, et al.. (2016). Successful Use of Afatinib After Erlotinib-induced Pneumonitis in a Patient With Epidermal Growth Factor Receptor-mutant Lung Cancer. Clinical Lung Cancer. 18(1). e81–e83.
12.
Jakubowski, Christopher, et al.. (2016). FAT1 Mutations Influence Time to First Treatment in Untreated CLL. Blood. 128(22). 4349–4349.
13.
Jakubowski, Christopher, Emily Vertosick, Brian R. Untch, et al.. (2016). Complete metastasectomy for renal cell carcinoma: Comparison of five solid organ sites. Journal of Surgical Oncology. 114(3). 375–379. 34 indexed citations
14.
Chevinsky, Michael, Alexander Sankin, Andrew Winer, et al.. (2015). Pathological Stage T3a Significantly Increases Disease Recurrence across All Tumor Sizes in Renal Cell Carcinoma. The Journal of Urology. 194(2). 310–315. 35 indexed citations
15.
Mano, Roy, Emily Vertosick, Alexander Sankin, et al.. (2014). Subcentimeter Pulmonary Nodules are Not Associated with Disease Progression in Patients with Renal Cell Carcinoma. The Journal of Urology. 193(3). 776–782. 13 indexed citations
16.
Goraczniak, Rafal, B. Wall, Mark A. Behlke, et al.. (2013). U1 Adaptor Oligonucleotides Targeting BCL2 and GRM1 Suppress Growth of Human Melanoma Xenografts In Vivo. Molecular Therapy — Nucleic Acids. 2. e92–e92. 5 indexed citations
17.
Jakubowski, Christopher, et al.. (2009). iTriplet, a rule-based nucleic acid sequence motif finder. Algorithms for Molecular Biology. 4(1). 14–14. 25 indexed citations
18.
Gokal, Ram, Christopher Jakubowski, Jennie King, et al.. (1988). Outcome in Patients on Continuous Ambulatory Peritoneal Dialysis and Haemodialysis: 4-Year Analysis of a Prospective Multicentre Study. The Journal of Urology. 139(5). 1137–1137. 24 indexed citations
19.
Gokal, Ram, Jennie King, Stephen Bogle, et al.. (1987). OUTCOME IN PATIENTS ON CONTINUOUS AMBULATORY PERITONEAL DIALYSIS AND HAEMODIALYSIS: 4-YEAR ANALYSIS OF A PROSPECTIVE MULTICENTRE STUDY. The Lancet. 330(8568). 1105–1109. 171 indexed citations
20.
Gokal, R, R. A. Baillod, Stephen Bogle, et al.. (1987). Multi-Centre Study on Outcome of Treatment in Patients on Continuous Ambulatory Peritoneal Dialysis and Haemodialysis. Nephrology Dialysis Transplantation. 2(3). 172–178. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Isabel Martínez Breakdown of academic impact, for papers by Marcel Soesan Breakdown of academic impact, for papers by Xiaojiang Zhan Breakdown of academic impact, for papers by Mark Jesky Breakdown of academic impact, for papers by Alessandra Raimondi Breakdown of academic impact, for papers by Els Vercammen Breakdown of academic impact, for papers by Kun‐Yuan Chiu Breakdown of academic impact, for papers by Giuliano Boscutti Breakdown of academic impact, for papers by Habeeb Majeed Breakdown of academic impact, for papers by Soon Bae Kim
Rankless by CCL
2026